Short Interest in BioStem Technologies, Inc. (OTCMKTS:BSEM) Increases By 38.8%

BioStem Technologies, Inc. (OTCMKTS:BSEM) was the target of a significant increase in short interest in December. As of December 31st, there was short interest totalling 191,200 shares, an increase of 38.8% from the December 15th total of 137,800 shares. Based on an average trading volume of 98,300 shares, the short-interest ratio is presently 1.9 days.

BioStem Technologies Stock Up 1.9 %

Shares of OTCMKTS BSEM traded up $0.29 during midday trading on Wednesday, hitting $15.63. The company had a trading volume of 84,832 shares, compared to its average volume of 49,659. The business has a 50-day simple moving average of $15.45 and a two-hundred day simple moving average of $12.60. BioStem Technologies has a twelve month low of $4.41 and a twelve month high of $28.26. The firm has a market capitalization of $260.30 million, a price-to-earnings ratio of 22.99 and a beta of -0.53.

BioStem Technologies (OTCMKTS:BSEM) last posted its earnings results on Tuesday, November 12th. The company reported $0.32 earnings per share for the quarter, beating the consensus estimate of $0.31 by $0.01. The firm had revenue of $82.56 million during the quarter, compared to analyst estimates of $78.22 million. On average, equities analysts forecast that BioStem Technologies will post 1.41 EPS for the current year.

BioStem Technologies Company Profile

BioStem Technologies, Inc, a life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services. It develops various biologic stem cell based alternative products, as a treatment for ailments, such as joint pain, tendon and ligament injuries, neurodegenerative, and autoimmune diseases.